glp 1 agonist clinical trials Cardiovascular outcomes in major with GLP-1 receptor agonists Many people remain excluded from

These are prescribed by a clinician, tailored by an RDN to relevant medical conditions, and covered by health insurance

Read on to learn more about weight loss injectables and if they're right for you: This content is not a substitute for professional medical advice or diagnosis

She has been writing for Everyday Health since 2025, and has also been published on NBCNe

One example is orforglipron , an oral GLP-1 for the treatment of type 2 diabetes and obesity

doi: 10.1210/jcem-63-2-492 2 GasbjergLSHelstedMMHartmannBJensenMHGabeMBNSparre-UlrichAHet al

In metabolic dysfunction-related steatohepatitis (MASH), preclinical models show GLP-1s reduced hepatic inflammation, lipid accumulation, and fibrosis-related markers